Head-to-head · verified 2026-08-05
Fridays vs. Noom Med: prices, fine print, and the honest verdict
Published pricing is incomplete on at least one side, so this matchup compares what can be verified — disclosure, terms, model — and says plainly where you'll need figures in writing.
- Fridays
- Official site
- joinfridays.com ↗
- Tirzepatide, all-in at 10 mg
- $359/mo
- Semaglutide, all-in
- $175/mo
- Membership fee
- None
- Prepaid / multi-month
- $240/mo effective — annual plan
- Commitment
- annual plan for lowest rate
- Cancellation
- not published
- Pharmacy
- not named
- First-year total (standing rate)
- $4,308
- Price evidence
- Third-party-reported
- Last verified
- 2026-08-05
- Noom Med
- Official site
- www.noom.com ↗
- Tirzepatide, all-in at 10 mg
- Not offered
- Semaglutide, all-in
- $199/mo
- Brand medications
- brand GLP-1 pathways described
- Membership fee
- None
- Commitment
- 12-week cycles
- Cancellation
- 12-week billing cycles
- Pharmacy
- Tailor Made Compounding (named)
- Price evidence
- Source-verified
- Last verified
- 2026-08-08
Tirzepatide pricing
Fridays: $359 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $240/mo (annual plan). Noom Med does not offer tirzepatide.
Semaglutide pricing
On semaglutide, Fridays wins at $175 versus $199 all-in — $24/mo apart. Fridays: Semaglutide runs $175 a month all-in. Noom Med: Semaglutide runs $199 a month all-in — capped at 0.6 mg, a quarter of the trial dose.
Transparency
Fridays: Third-party-reported (verified 2026-08-05); dispensing pharmacy not publicly named. Noom Med: Source-verified (verified 2026-08-08); names its pharmacy — Tailor Made Compounding (named). In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.
Commitment & cancellation
Fridays: annual plan for lowest rate; not published. Noom Med: 12-week cycles; 12-week billing cycles.
Fridays: $359/mo verified all-in; Noom Med: no published price captured; best prepaid: Fridays at $240/mo effective; semaglutide: Fridays $175 vs Noom Med $199; verified floor $215 (NexLife); brand rails $349–$449. Basis: all-in monthly, 10 mg maintenance, capture-dated in the dataset.
Two ladders, side by side
Titration is where these pricing structures stop being abstractions: Fridays holds $359 on every rung (four-month titration: exactly $1,436). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.
The semaglutide board
On semaglutide, Fridays prices at $175 against $199 all-in. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.
The five normalizations, applied to this pair
1 · All-in, not advertised. Fridays's ranked figure is $359, with no membership to add; Noom Med publishes no figure to normalize. 2 · Maintenance basis. Fridays is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. Fridays: standing $359, prepaid $240 effective (annual plan) — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Fridays: third-party-reported, read 2026-08-05; Noom Med: source-verified, read 2026-08-08. 5 · Pharmacy weighed. Fridays names no pharmacy; Noom Med names Tailor Made Compounding (named) — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.
Fine print, itemized
Fridays: no membership — the medication figure is the billed figure; prepaid annual plan at $240/mo effective; not published; commitment: annual plan for lowest rate. Noom Med: no membership — the medication figure is the billed figure; 12-week billing cycles; commitment: 12-week cycles. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.
Transparency, audited
Fridays carries third-party-reported pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Noom Med carries source-verified pricing (last read 2026-08-08); pharmacy disclosure is its strong suit — Tailor Made Compounding (named), named 503A/503B partner. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.
Switching between them
The switch mechanics are symmetric: new intake, new script, new pharmacy, old plan cancelled in writing. Budget a shipping-gap week, confirm the destination program's price at your current dose (not its starter figure), and if the move is also a molecule change, loop the prescriber in per the switching guide.
Refills, shipping, and the week-to-week reality
Logistics decide more churn than price does, so put them on the record: Fridays: shipping included; consultation included. Noom Med: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.
Who should pick which
Pick Fridays if the semaglutide line is cheaper here; you want a price that survives titration; you'll prepay for the $240 effective rate. Pick Noom Med if a named pharmacy is non-negotiable for you. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.
If neither one fits
Widen the frame one step and the strongest adjacent options are Lavender Sky Health at $352 (dose-scaled, $25 membership included); Henry Meds at $349 (flat, no membership); TrimRx at $349 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.
The brand benchmark both must beat
Neither program exists in a vacuum: FDA-approved Zepbound sits at $449/month at maintenance (LillyDirect or retail KwikPens, ~$350 on TrumpRx, ~$50 for newly eligible Medicare patients), and Wegovy at a flat $349. The cheaper of these two compounded options saves $1,080/year against the Zepbound benchmark — the number that has to justify accepting a not-FDA-reviewed product, per the full trade analysis. When a compounded quote drifts above ~$350, this benchmark starts winning the argument on its own.
The verdict
With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.
Quick answers
Which is cheaper, Fridays or Noom Med?
Published pricing is incomplete on at least one side; the honest answer is to request current all-in figures in writing from both.
Who wins on semaglutide?
Fridays at $175/mo all-in versus $199.
Can I switch between them?
Yes — patients move between telehealth programs routinely; you'll complete the new program's intake and prescriptions restart there. If you're also switching molecule or from compounded to brand, loop in the prescriber; our switching guide covers the clinical side.
Which is easier to cancel, Fridays or Noom Med?
Fridays: not published Noom Med: 12-week billing cycles Cancel in writing either way; memberships cancel separately.
Is there a brand alternative to both?
Yes — Zepbound at $299–$449 via LillyDirect/retail (about $350 on TrumpRx; ~$50 for newly eligible Medicare patients) and Wegovy at a flat $349: FDA-approved products whose prices now sit close enough to make the comparison real.